DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA™ (NYSE:IQV) today announced it has received the Frost & Sullivan’s 2018 Global Enterprise Quality Management Solutions for Life Sciences Product Leadership award. IQVIA Technologies’ SmartSolve®, a best-in-class, integrated enterprise quality management solution (EQMS), was selected for its unique ability to address the needs of life sciences companies in quality management.
Frost & Sullivan's annual Product Leadership Award recognizes the company that consistently provides the highest standards of product, service quality, or innovation to customers.
"Life sciences companies are in need of a partner that has a highly effective global resource pool with domain experience as well as an in-depth knowledge of global quality compliance requirements and the latest in regulatory changes and trends,” said Sankara Narayanan, senior analyst, Manufacturing Leadership with Frost & Sullivan. “IQVIA has secured a competitive edge with the ability to offer industry-leading innovation, technology updates and global support to its customers."
SmartSolve helps life sciences companies optimize operations across the value chain to manage quality issues, comply with regulations, and mitigate risk. The solution’s resources are powered by the IQVIA CORE™, which reflects more than two decades of regulatory and quality expertise dedicated primarily to the life sciences, including the pharmaceutical, biologics, medical device, and blood and tissue segments.
“We are honored to receive this recognition from Frost & Sullivan,” said Tal Rosenberg, senior vice president, Global Technology Solutions at IQVIA. “IQVIA Technologies’ SmartSolve EQMS suite is a molecule-to-market solution that addresses complex and global quality and compliance requirements. This award is a testament to our position as a global leader for quality management.”
IQVIA was recognized with the most recent award at Frost & Sullivan’s 2018 Excellence in Best Practices Awards Gala on July 10, 2019 in London and on July 17, 2019 in San Diego.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 61,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing the information that helps their customers drive human health outcomes forward. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?
We're available during standard business hours.
U.S. Toll-Free only
+1 866 267 4479
For international call please find a number in our toll-free list.
Please note that forms have been updated on SC9 PROD, it may be good to update the SC9 DEV forms with SC9 PROD.